市售透明质酸水凝胶(Restylane)作为牙髓再生可注射支架的体外评价
本研究体外评价美国食品药品监督管理局批准的透明质酸凝胶Restylane作为再生牙髓治疗支架的可行性。将根尖乳头干细胞单独培养或与Restylane或Matrigel混合培养,检测细胞活力与矿化分化。Restylane组细胞活力随时间显著增加,并促进碱性磷酸酶活性及牙本质涎磷蛋白等成牙本质标志物表达上调,提示其可能是有前景的支架材料。
要点
- Restylane与Matrigel封装均较对照组降低根尖乳头干细胞活力。
- Restylane组细胞活力3天内显著增加,Matrigel组显著下降。
- Restylane促进碱性磷酸酶活性和成牙本质相关基因表达上调。
核心结论
- 美国食品药品监督管理局批准的透明质酸基可注射凝胶促进根尖乳头干细胞存活、矿化及向成牙本质细胞表型分化,可能成为再生牙髓治疗的有前景支架材料。
研究设计与样本
- 体外研究:根尖乳头干细胞单独培养或与Restylane或Matrigel支架混合培养,设基础培养基对照组。
- 细胞活力检测于培养6、24、72小时进行。
- 矿化分化实验:分化培养基培养7天检测碱性磷酸酶活性,培养14天用定量逆转录聚合酶链反应检测基因表达。
主要发现
- Restylane或Matrigel封装均较对照组降低细胞活力。
- Restylane组细胞活力在3天内显著增加,而Matrigel组显著下降。
- Restylane组碱性磷酸酶活性及牙本质涎磷蛋白、牙本质基质酸性磷蛋白-1、基质细胞外磷酸糖蛋白表达较对照组显著上调。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Regenerative endodontic procedures (REPs) are viable alternatives for treating immature teeth, yet these procedures do not predictably lead to pulp-dentin regeneration. A true bioengineering approach for dental pulp regeneration requires the incorporation of a scaffold conducive with the regeneration of the pulp-dentin complex. Several materials have been proposed as scaffolds for REPs; nonetheless, the majority are not eligible for immediate clinical chairside use. Thus, the aim of this study was to evaluate Restylane, a Food and Drug Administration-approved hyaluronic acid-based gel, as possible scaffold for REPs. METHODS: Stem cells of the apical papilla (SCAP) were cultured either alone or in mixtures with either Restylane or Matrigel scaffolds. Groups were cultured in basal culture medium for 6, 24, and 72 hours, and cell viability was assessed. For the mineralizing differentiation experiments, groups were cultured in differentiation medium either for 7 days and processed for alkaline phosphatase activity or for 14 days and processed for gene expression by using quantitative reverse-transcription polymerase chain reaction. SCAP in basal medium served as control. RESULTS: Cell encapsulation in either Restylane or Matrigel demonstrated reduced cell viability compared with control. Nonetheless, cell viability significantly increased in the Restylane group in the course of 3 days, whereas it decreased significantly in the Matrigel group. Restylane promoted significantly greater alkaline phosphatase activity and upregulation of dentin sialophosphoprotein, dentin matrix acidic phosphoprotein-1, and matrix extracellular phosphoglycoprotein, compared with control. CONCLUSIONS: A Food and Drug Administration-approved hyaluronic acid-based injectable gel promoted SCAP survival, mineralization, and differentiation into an odontoblastic phenotype and may be a promising scaffold material for REPs.
引用
- Chrepa V, Austah O, Diogenes A, et al. Evaluation of a Commercially Available Hyaluronic Acid Hydrogel (Restylane) as Injectable Scaffold for Dental Pulp Regeneration: An In Vitro Evaluation. J Endod. 2016. PMID: 28041686. doi:10.1016/j.joen.2016.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。